ZimVie Inc.

    ZimVie Inc.

    NNASDAQ:ZIMV
    - -
    USD
    - -
    - -
    ZimVie Inc.
    NASDAQ:ZIMV
    (Nasdaq Stock Market)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    42.11
    40.44
    34.96
    18.1
    17.75
    17.29
    16.41
    16.03
    Revenue per Share
    -17.64
    -1.07
    -6.86
    -3.65
    -2.45
    -14.87
    -0.94
    -0.7
    Basic EPS, GAAP
    4.36
    2.54
    1.83
    0.29
    -0.07
    0.93
    0.27
    0.2
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    20.71
    - -
    - -
    - -
    Dividend per Share
    - -
    65.42
    56.93
    57.25
    -1.81
    -16.65
    -17.02
    -17.05
    Book Value per Share
    - -
    13.48
    12.48
    15.99
    13.79
    1.25
    1.14
    2.17
    Tangible Book Value per Share
    26
    26
    26
    26
    26
    26
    27
    28
    Basic Weighted Avg Shares
    1,099
    1,056
    912
    472
    463
    457
    450
    443
    Sales/Revenue/Turnover
    -2.82
    -2.16
    -7.54
    7.03
    -3.74
    -2.46
    -0.47
    1.42
    Operating Margin (%)
    148
    135
    134
    130
    123
    122
    34
    35
    Depreciation Expense
    -460
    -28
    -179
    -95
    -64
    -393
    -26
    -19
    Net Income, GAAP
    - -
    - -
    - -
    20.33
    - -
    - -
    - -
    2,225.83
    Effective Tax Rate (%)
    -41.89
    -2.65
    -19.63
    -20.17
    -13.79
    -85.98
    -5.74
    -4.39
    Profit Margin (%)
    - -
    320
    300
    352
    321
    309
    123
    151
    Working Capital
    - -
    73
    58
    45
    542
    518
    229
    231
    LT Debt
    - -
    1,668
    1,491
    1,451
    759
    409
    382
    413
    Total Equity
    - -
    - -
    - -
    1.7
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    -6.07
    - -
    - -
    - -
    -194.07
    Return on Capital (%)
    - -
    -3.28
    -11.22
    -6.39
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    4
    4
    4
    LT Borrowings
    220
    221
    221
    LT Finance Leases
    8
    8
    10
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    28
    28
    28
    Market Capitalization
    381
    297
    259

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    257
    251
    260
    Cash, Cash Equivalents & STI
    75
    67
    70
    Accounts Receivable, Net
    65
    77
    85
    Inventories
    75
    78
    84
    Total Current Liabilities
    134
    117
    110
    Payables & Accruals
    58
    60
    74
    ST Debt
    4
    4
    4
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -22.76%
    -6.79%
    Free Cash Flow
    - -
    -338.49%
    -69.62%
    Net Income, GAAP
    - -
    176.41%
    -93.43%
    Sales/Revenue/Turnover
    - -
    -13.33%
    -1.68%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    120
    119
    105
    -196
    457
    2024
    118
    117
    103
    112
    450
    2025
    112
    117
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -1.14
    -0.89
    -0.19
    - -
    -14.87
    2024
    -0.29
    -0.15
    -0.08
    -0.43
    -0.94
    2025
    -0.05
    -0.14
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    • ZimVie Announces Completion of its Acquisition by ARCHIMED

    • ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED

    • ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV

    • SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV and CIO on Behalf of Shareholders

    • ZimVie Reports Second Quarter 2025 Financial Results

    • ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025

    • ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China

    • ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV

    • SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders

    • $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ZimVie Inc. (NASDAQ: ZIMV)

    • Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders

    • ZIMV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ZimVie Inc. Is Fair to Shareholders

    • ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash

    • ZimVie: Screening Cheap (Rating Upgrade)

    • ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite

    • ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan

    • ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference

    • ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript

    • ZimVie Reports First Quarter 2025 Financial Results

    • ZimVie to Report First Quarter 2025 Financial Results on May 8, 2025